News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Rodman & Renshaw Leads Wall Street For Biotechnology Deals In 2004; Forthcoming London Conference Highlights Exciting Sector Opportunities
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Rodman & Renshaw, the privately-held, full service investment bank, is very proud to announce that it has been rated number 1 on Wall Street for the number of biotechnology deals completed in 2004, according to statistics from PlacementTracker.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
June 16, 2025
·
2 min read
·
Jef Akst
Cancer
Practice-Changing Data, Innovative Modalities and China in Focus at #ASCO25
May 27, 2025
·
7 min read
·
Tristan Manalac
Cancer
AACR 2025 Tracker: Merck, GSK, Roche and More Present Key Data
April 30, 2025
·
8 min read
·
BioSpace Editorial Staff
Duchenne muscular dystrophy
Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings
March 27, 2025
·
8 min read
·
Heather McKenzie